Tax Inversion Action? Clock Ticks on Pfizer-Allergan Merger
As the Pfizer-Allergan merger talks heat up, shining yet another spotlight on the tax inversion issue, a Goldman Sachs report notes that it is up to the U.S. Treasury and IRS to stem flood of corporations fleeing the U.S. tax system for more friendly climates abroad.
Pfizer / Allergan acquisition would result in a tax inversion, as clock is ticking
If drug giant Pfizer Inc. is successful in . . .
SORRY! This content is exclusively for paying members. If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.
|
